ProShares UltraShort Nasdaq Biotech (BIS)

Add to Watchlists
Create an Alert
26.28 -0.60  -2.23% NASDAQ Jul 31, 20:00 Delayed 2m USD
View Full Chart
BIS Price Chart

BIS Description

ProShares UltraShort Nasdaq Biotech is a long-short equity fund managed by ProShares that tracks the NASDAQ Biotechnology TR USD index and has 115.42M USD assets under management. The fund has a net expense ratio of 0.95% and is traded on the NASDAQ.

BIS Key Info

Expense Ratio (1-9-15) 0.95%
Assets Under Management (7-31-15) 115.42M
30-Day Average Volume (7-31-15) 605916.6
Net Asset Value (7-31-15) 26.32
Discount or Premium to NAV (7-31-15) -0.15%
Turnover Ratio --

BIS Asset Allocation

Type % Net % Long % Short
Cash 299.8% 299.8% 0.00%
Stock -199.7% 0.13% 199.8%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other -0.07% 0.00% 0.07%
As of June 30, 2015

BIS Region Exposure

Americas --
North America --
Latin America --
Greater Europe --
United Kingdom --
Europe Developed --
Europe Emerging --
Africa/Middle East --
Greater Asia --
Japan --
Australasia --
Asia Developed --
Asia Emerging --
Market Classification
% Developed Markets --
% Emerging Markets --
Date Unavailable
Region breakdown data is calculated by using the long position holdings of the portfolio.

BIS Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 0.00%
Industrials 0.00%
Real Estate 0.00%
Technology 0.00%
Utilities 0.00%
As of June 30, 2015

BIS Stock Market Capitalization

Giant --
Large --
Medium --
Small --
Micro --
As of June 30, 2015
View More Holdings

BIS Top 10 Holdings

Symbol Name % Weight Price % Chg
-- Nasdaq Biotechnology Index Swap Bank Of America, Na 74.66% -- --
-- Nasdaq Biotechnology Index Swap Ubs Ag 61.73% -- --
-- Nasdaq Biotechnology Index Swap Societe Generale 52.92% -- --
-- Nasdaq Biotechnology Index Swap Deutsche Bank Ag 9.12% -- --
-- Nasdaq Biotechnology Index Swap Credit Suisse International 1.24% -- --
-- Nasdaq Biotechnology Index Swap Morgan Stanley & Co. International Plc 0.13% -- --
-- Nasdaq Biotechnology Index Swap Morgan Stanley & Co. International Plc - Ca 0.13% -- --
-- Ishares Biotech (Ibb) Swap Morgan Stanley & Co. International Plc 0.06% -- --
-- Nasdaq Biotechnology Index Swap Citibank, N.A. 0.03% -- --
-- Ishares Biotech (Ibb) Swap Bank Of America, Na 0.01% -- --
As of June 30, 2015
Advertisement

BIS Basic Info

Style
Broad Asset Class Alternative
Broad Category Alternative
Prospectus Objective Specialty - Health
Fund Owner Firm Name ProShares
Benchmark Index
NASDAQ Biotechnology TR USD -200.0%

BIS Manager Info

Name Tenure
Charles Lowery 1.75 yrs
Michael Neches 1.75 yrs

BIS Risk Info

Beta -1.421
Max Drawdown (All) 98.40%
Historical Sharpe (10y) --
Historical Sortino (All) -1.487
30-Day Rolling Volatility 49.06%
Daily Value at Risk (VaR) 1% (All) 6.75%
Monthly Value at Risk (VaR) 1% (All) 23.56%

BIS Fundamentals

Dividend Yield TTM (7-31-15) 0.00%
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio --
Weighted Average Price to Book Ratio --
Weighted Median ROE --
Weighted Median ROA --
Forecasted Dividend Yield --
Forecasted PE Ratio --
Forecasted Price to Sales Ratio --
Forecasted Price to Book Ratio --
Number of Holdings 19
As of June 30, 2015

BIS Growth Estimates

Forecasted 5 Yr Earnings Growth --
Forecasted Book Value Growth --
Forecasted Cash Flow Growth --
Forecasted Earnings Growth --
Forecasted Revenue Growth --
As of June 30, 2015

BIS Performance

  Returns Total Returns
1M -8.50% -8.50%
3M -26.82% -26.82%
6M -34.90% -34.90%
1Y -64.12% -64.12%
3Y -92.75% -92.75%
5Y -98.16% -98.16%
As of July 31, 2015

BIS Net Flows

1M 7.026M
3M 26.55M
6M 89.60M
YTD 106.44M
1Y 117.40M
3Y 200.55M
5Y 202.79M
As of July 31, 2015

BIS Attributes

Key Dates
Inception Date 4/6/2010
Last Annual Report Date 5/31/2014
Last Prospectus Date 1/9/2015
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund Yes
Leveraged Fund Yes
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund Yes
Has Dividend Investment Plan No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.